ALCGM logo

Cegedim SA Stock Price

ENXTPA:ALCGM Community·€156.5m Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 3 Fair Values set on narratives written by author

ALCGM Share Price Performance

€11.40
0.55 (5.07%)
€13.67
Fair Value
€11.40
0.55 (5.07%)
16.6% undervalued intrinsic discount
€13.67
Fair Value
Price €11.40
AnalystConsensusTarget €13.67
AnalystLowTarget €11.00
AnalystHighTarget €14.00

ALCGM Community Narratives

·
Fair Value €13.67 16.6% undervalued intrinsic discount

Visiodent Integration And Allianz Contract Will Improve Future Profitability In Healthcare Software

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
·
Fair Value €11 3.6% overvalued intrinsic discount

Legacy Challenges Will Test Healthcare Digitalization As Modest Opportunities Open

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
·
Fair Value €14 18.6% undervalued intrinsic discount

Healthcare Digitization And AI Analytics Will Expand Market Access

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
€14
18.6% undervalued intrinsic discount
Revenue
2.61% p.a.
Profit Margin
5.3%
Future PE
6.96x
Price in 2029
€19.02
€13.67
16.6% undervalued intrinsic discount
Profit Margin
3.12%
Future PE
11.22x
Price in 2028
€18.25

Trending Discussion

Updated Narratives

ALCGM logo

ALCGM: Higher Margin Outlook Will Support Future Re Rating Potential

Fair Value: €14 18.6% undervalued intrinsic discount
0 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
ALCGM logo

Legacy Challenges Will Test Healthcare Digitalization As Modest Opportunities Open

Fair Value: €11 3.6% overvalued intrinsic discount
0 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
ALCGM logo

Visiodent Integration And Allianz Contract Will Improve Future Profitability In Healthcare Software

Fair Value: €13.67 16.6% undervalued intrinsic discount
1 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Good value with moderate growth potential.

2 Risks
4 Rewards

Cegedim SA Key Details

€649.2m

Revenue

€377.4m

Cost of Revenue

€271.7m

Gross Profit

€262.3m

Other Expenses

€9.4m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
Sep 24, 2026
0.68
41.86%
1.45%
79.1%
View Full Analysis

About ALCGM

Founded
1969
Employees
6344
CEO
Jean-Claude Labrune
WebsiteView website
www.cegedim.com

Cegedim SA operates as a technology and services company in the field of digital data flow management for healthcare ecosystem and B2B in France, rest of Europe, and internationally. It operates through Health Insurance, HR and E-Services; Healthcare Professionals; and Cloud & Support segments. The Health Insurance, HR and E-Services segment markets various products and services to insurance companies, mutual insurers, personal protection insurers, and insurance brokers, as well as engages in the interactions between these entities and healthcare professionals. This segment also provides solutions for IT services and hosting, digitization, human resources and payroll management outsourcing, electronic data exchange, and data processing services. The Healthcare Professionals division sells management software, databases, and solutions to doctors, paramedical professionals, pharmacists, and healthcare facilities. It also operates as a business software publisher for healthcare and insurance professionals. The company was incorporated in 1969 and is headquartered in Boulogne-Billancourt, France. Cegedim SA is a subsidiary of FCB SAS.

Recent ALCGM News & Updates

Narrative Update Jun 02

ALCGM: Higher Margin Outlook Will Support Future Re Rating Potential

Analysts have trimmed their price target on Cegedim from €17 to €14, citing updated assumptions about revenue growth, profit margins and the stock’s future P/E multiple. What's in the News No recent company specific news items were provided in the sources above.

Recent updates

No updates